The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC).
 
Qiang Xue
No Relationships to Disclose
 
Baogui Wang
No Relationships to Disclose
 
Xiaona Wang
No Relationships to Disclose
 
Xuewei Ding
No Relationships to Disclose
 
Yong Liu
No Relationships to Disclose
 
Xuejun Wang
No Relationships to Disclose
 
Ning Liu
No Relationships to Disclose
 
Hongjie Zhan
No Relationships to Disclose
 
Bin Ke
No Relationships to Disclose
 
Bin Li
No Relationships to Disclose
 
Mingzhi Cai
No Relationships to Disclose
 
Jingyu Deng
No Relationships to Disclose
 
Liangliang Wu
No Relationships to Disclose
 
Wenbai Huang
No Relationships to Disclose
 
Hongmin Liu
No Relationships to Disclose
 
Yan Sun
No Relationships to Disclose
 
Han Liang
No Relationships to Disclose